RNA — AVIDITY BIOSCIENCES ORD

Ownership history in KRYGER CAPITAL Ltd  ·  1 quarter on record

This page tracks every 13F SEC filing in which KRYGER CAPITAL Ltd reported a position in AVIDITY BIOSCIENCES ORD (RNA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
5.82% (2025 Q4)
Avg. % of fund
5.82%
First filed
2025 Q4
Last filed
2025 Q4
Quarters held
1
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 INITIATED 1,045,320 — — 5.82% $75.4M —
% of Fund (quarterly)    RNA price (monthly, adj. close)

Other funds also holding RNA

As of 2025 Q4 — sorted by position size

ALETHEA CAPITAL MANAGEMENT, LLC 3Y 7Y 15.62% Slotnik Capital, LLC 12.01% Twin Securities, Inc. 3Y 7Y 10.07% Sand Grove Capital Management LLP 3Y 7Y 8.11% HARVEST MANAGEMENT LLC 3Y 7Y 7.61% Slotnik Capital, LLC 6.72% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 6.39% TIG Advisors, LLC 3Y 7Y 6.02% PSquared Asset Management AG 3Y 7Y 5.68% Athos Capital Ltd 3Y 7Y 5.1%
← Back to KRYGER CAPITAL Ltd Holdings